The securities investigation adds legal overhang; monitor for class action filings and any additional disclosures from Teladoc regarding BetterHelp trends and revenue visibility. The guidance cut signals ongoing operational challenges, and further downside risk remains if the investigation uncovers material misstatements.
Price Chart
Executive Summary
Teladoc Health (TDOC) shares fell over 28% after reporting Q2 2026 revenue of $606.9M, below the consensus range of $615M-$628M, and cutting full-year 2026 revenue guidance to $2.36B-$2.45B from prior $2.47B-$2.59B. A securities investigation has been launched by Levi & Korsinsky regarding potentially misleading statements about forward revenue outlook.
Key Financial Metrics
Key Facts
- Q2 2026 consolidated revenue of $606.9M, below consensus range of $615M-$628M
- Full-year 2026 revenue guidance cut to $2.36B-$2.45B from prior $2.47B-$2.59B
- Stock dropped more than 28% following the earnings release and guidance cut
- EPS of $-0.21 beat consensus of $-0.24 (12.5% beat) but was overshadowed by revenue miss and guidance reduction
- BetterHelp division revenue decline accelerated beyond prior expectations, with insurance capacity not expanding as fast as demand
Financial Impact
Revenue miss of ~2.35% vs consensus midpoint; full-year guidance cut by ~4.5% at midpoint; stock decline of >28%
Risk Factors
- Potential securities class action lawsuit and associated legal costs
- Further revenue deterioration in BetterHelp division
- Loss of investor confidence leading to sustained stock price weakness
- Possible restatement or additional guidance revisions
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-prn-302845696 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 11, 2026 21d ago | 144 | $6.16 $6.30 | ▲ +2.27% | ▲ +2.49% | $5.52 (−10.39%) |
Sep 3, 2026 29d ago | Insider Cluster | $6.28 $6.50 | ▲ +3.50% | ▲ +4.71% | $5.52 (−12.10%) |
Sep 2, 2026 4w ago | 144 | $6.46 $6.09 | ▼ −5.73% | ▼ −4.77% | $5.52 (−14.55%) |
Aug 7, 2026 8w ago | Press Release | $7.13 $6.81 | ▲ +4.49% | ▲ +4.89% | $5.52 (+22.58%) |
Jul 31, 2026 9w ago | Press Release | $6.68 $7.08 | ▼ −5.99% | ▼ −3.96% | $5.52 (+17.37%) |
Jun 29, 2026 13w ago | 144 | $8.69 $9.29 | ▲ +6.90% | ▲ +5.52% | $5.52 (−36.48%) |
Jun 11, 2026 16w ago | 144 | $7.31 $7.59 | ▲ +3.83% | ▲ +3.40% | $5.52 (−24.49%) |
Jun 11, 2026 16w ago | Institutional Cluster | $7.31 $7.59 | ▲ +3.83% | ▲ +3.40% | $5.52 (−24.49%) |
Jun 2, 2026 17w ago | 144 | $7.09 $7.03 | ▼ −0.85% | ▲ +2.97% | $5.52 (−22.14%) |
Jun 2, 2026 17w ago | 144 | $7.09 $7.03 | ▼ −0.85% | ▲ +2.97% | $5.52 (−22.14%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access